Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.
The precise molecular mechanisms enabling cancer cells to metastasize from the primary tumor to different tissue locations are still largely unknown. Secretion of some proteins by metastatic cells could facilitate metastasis formation. The comparison of secreted proteins from cancer cells with diffe...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0104223 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849331852929662976 |
|---|---|
| author | Kevin T Sayers Alan D Brooks Thomas J Sayers Oleg Chertov |
| author_facet | Kevin T Sayers Alan D Brooks Thomas J Sayers Oleg Chertov |
| author_sort | Kevin T Sayers |
| collection | DOAJ |
| description | The precise molecular mechanisms enabling cancer cells to metastasize from the primary tumor to different tissue locations are still largely unknown. Secretion of some proteins by metastatic cells could facilitate metastasis formation. The comparison of secreted proteins from cancer cells with different metastatic capabilities in vivo might provide insight into proteins involved in the metastatic process. Comparison of the secreted proteins from the mouse breast cancer cell line 4T1 and its highly metastatic 4T1.2 clone revealed a prominent differentially secreted protein which was identified as SLPI (secretory leukocyte protease inhibitor). Western blotting indicated higher levels of the protein in both conditioned media and whole cell lysates of 4T1.2 cells. Additionally higher levels of SLPI were also observed in 4T1.2 breast tumors in vivo following immunohistochemical staining. A comparison of SLPI mRNA levels by gene profiling using microarrays and RT-PCR did not detect major differences in SLPI gene expression between the 4T1 and 4T1.2 cells indicating that SLPI secretion is regulated at the protein level. Our results demonstrate that secretion of SLPI is drastically increased in highly metastatic cells, suggesting a possible role for SLPI in enhancing the metastatic behavior of breast cancer cell line 4T1. |
| format | Article |
| id | doaj-art-e21abdef6dbe48dda3e10aafadbc4dcf |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-e21abdef6dbe48dda3e10aafadbc4dcf2025-08-20T03:46:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0198e10422310.1371/journal.pone.0104223Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.Kevin T SayersAlan D BrooksThomas J SayersOleg ChertovThe precise molecular mechanisms enabling cancer cells to metastasize from the primary tumor to different tissue locations are still largely unknown. Secretion of some proteins by metastatic cells could facilitate metastasis formation. The comparison of secreted proteins from cancer cells with different metastatic capabilities in vivo might provide insight into proteins involved in the metastatic process. Comparison of the secreted proteins from the mouse breast cancer cell line 4T1 and its highly metastatic 4T1.2 clone revealed a prominent differentially secreted protein which was identified as SLPI (secretory leukocyte protease inhibitor). Western blotting indicated higher levels of the protein in both conditioned media and whole cell lysates of 4T1.2 cells. Additionally higher levels of SLPI were also observed in 4T1.2 breast tumors in vivo following immunohistochemical staining. A comparison of SLPI mRNA levels by gene profiling using microarrays and RT-PCR did not detect major differences in SLPI gene expression between the 4T1 and 4T1.2 cells indicating that SLPI secretion is regulated at the protein level. Our results demonstrate that secretion of SLPI is drastically increased in highly metastatic cells, suggesting a possible role for SLPI in enhancing the metastatic behavior of breast cancer cell line 4T1.https://doi.org/10.1371/journal.pone.0104223 |
| spellingShingle | Kevin T Sayers Alan D Brooks Thomas J Sayers Oleg Chertov Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells. PLoS ONE |
| title | Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells. |
| title_full | Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells. |
| title_fullStr | Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells. |
| title_full_unstemmed | Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells. |
| title_short | Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells. |
| title_sort | increased secretory leukocyte protease inhibitor slpi production by highly metastatic mouse breast cancer cells |
| url | https://doi.org/10.1371/journal.pone.0104223 |
| work_keys_str_mv | AT kevintsayers increasedsecretoryleukocyteproteaseinhibitorslpiproductionbyhighlymetastaticmousebreastcancercells AT alandbrooks increasedsecretoryleukocyteproteaseinhibitorslpiproductionbyhighlymetastaticmousebreastcancercells AT thomasjsayers increasedsecretoryleukocyteproteaseinhibitorslpiproductionbyhighlymetastaticmousebreastcancercells AT olegchertov increasedsecretoryleukocyteproteaseinhibitorslpiproductionbyhighlymetastaticmousebreastcancercells |